Michael M. Millenson

Hematology | Oncology

3491 Commerce Ave
Willow Grove, PA 19090

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018.

NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 17, 2018

NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.

NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.

Journal: Oncoimmunology

Published: December 13, 2016

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 09, 2016

Low Level of Blood CD4+ T Cells Is an Independent Predictor of Inferior Progression-free Survival in Diffuse Large B-cell Lymphoma.

Low Level of Blood CD4+ T Cells Is an Independent Predictor of Inferior Progression-free Survival in Diffuse Large B-cell Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 11, 2016

High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.

High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 20, 2015

Cancer-Associated Venous Thromboembolic Disease, Version 1.2015.

Cancer-Associated Venous Thromboembolic Disease, Version 1.2015.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: September 12, 2015

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.

Journal: The New England journal of medicine

Published: December 09, 2014

Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.

Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.

Journal: Cancer

Published: December 23, 2013

Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.

Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.

Journal: Cancer genetics

Published: November 25, 2013

Venous thromboembolic disease.

Venous thromboembolic disease.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 15, 2013

Acute myeloid leukemia, version 2.2013.

Acute myeloid leukemia, version 2.2013.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: September 14, 2013

Myelodysplastic syndromes: clinical practice guidelines in oncology.

Myelodysplastic syndromes: clinical practice guidelines in oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: July 13, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026